Despite this challenging macro environment, we remain optimistic about the growth outlook of the Indian pharmaceutical companies
LKP Securities is bullish on State Bank of India with a price target of Rs 520.
Production linked incentive scheme is likely to add approximately 15% to the current market size of the pharma market once fully implemented
Torrent Pharma's consolidated revenue from operations stood at Rs 1,937 crore for the quarter under consideration